Abstract: A real-time low frame-rate video compression system and method that allows the user to perform face-to-face communication through an extremely low bandwidth network. At the encoder side, the system is able to automatically select only a few good faces from the original sequence with high visual quality and compress and transmit them. At the decoder side, the system use image-morphing based rendering method to generate a normal frame-rate video. Experimental results show that the system is superior to more traditional video codecs for low bit-rate face-to-face communication.

Abstract: A real-time low frame-rate video compression system and method that allows the user to perform face-to-face communication through an extremely low bandwidth network. The system and method employs image cropping and morphing to reduce frame rates. At the encoder side, the system is able to automatically select only a few good faces from the original sequence with high visual quality and compress and transmit them. At the decoder side, the system use image-morphing based rendering method to generate a normal frame-rate video. Experimental results show that the system is superior to more traditional video codecs for low bit-rate face-to-face communication.

Abstract: The invention generally relates to a method for pulmonary delivery of therapeutic, prophylactic and diagnostic agents to a patient wherein the agent is released in a sustained fashion, and to particles suitable for use in the method. In particular, the invention relates to a method for the pulmonary delivery of a therapeutic, prophylactic or diagnostic agent comprising administering to the respiratory tract of a patient in need of treatment, prophylaxis or diagnosis an effective amount of particles comprising a polycationic complexing agent which is complexed with a therapeutic, prophylactic or diagnostic agent or any combination thereof having a charge capable of complexing with the polycationic complexing agent upon association with the bioactive agent. The particles can further comprise a pharmaceutically acceptable carrier. The amount of polycationic complexing agent present in the particles is an amount sufficient to sustain the release of diagnostic, therapeutic or prophylactic agent from the particles.

Abstract: A controller for, related method of controlling a switch of, a power converter and a power converter employing the same. The controller is employable with a power converter including a switch of a power train configured to conduct for a duty cycle and provide a regulated output characteristic at an output thereof. In one embodiment, the controller includes a sparse analog-to-digital converter configured to determine a difference between the output characteristic and a desired characteristic and provide an error signal representing the difference in discrete steps. A magnitude of the discrete steps is small when the difference is small and the magnitude of the discrete steps is larger when the difference is larger. The controller also includes a duty cycle processor configured to provide a digital duty cycle signal to control the duty cycle of the switch as a function of the error signal.

Abstract: A controller for, related method of controlling a switch of, a power converter, and a power converter employing same. The controller is employable with a power train of a power converter including a switch configured to conduct for a duty cycle and provide a regulated output characteristic at an output thereof. In one embodiment, the controller includes an oscillator configured to provide a clock signal having multiple phases. The controller also includes a modulator configured to select a phase of the clock signal as a function of a portion of a digital duty cycle signal to refine a resolution of the duty cycle and provide a signal to control the duty cycle of the switch as a function of the digital duty cycle signal.

Abstract: The invention is directed to improved coated metal fluoride single crystal optical elements suitable for use in below 250 nm optical lithography, and particularly below 200 nm lithography. The coated elements of the invention can be lenses, windows, prisms and other elements used in lithographic methods, including the laser sources used therein. The invention is also directed to a method of removing the quasi-Bielby layer formed when a shaped optical element is polished. Removal of the quasi-Bielby layer prior to coating results in improved durability and optical transmission characteristics of the coated lenses. The coating material can be any material that does not impede the transmission of below 250 nm electromagnetic radiation. Fluorine doped silicon dioxide is the preferred coating material.

Abstract: The techniques and mechanisms described herein are directed to a system for stylizing video, such as interactively transforming video to a cartoon-like style. Briefly stated, the techniques include determining a set of volumetric objects within a video, each volumetric object being a segment. Mean shift video segmentation may be used for this step. With that segmentation information, the technique further includes indicating on a limited number of keyframes of the video how segments should be merged into a semantic region. Finally, a contiguous volume is created by interpolating between keyframes by a mean shift constrained interpolation technique to propagate the semantic regions between keyframes.

Abstract: A controller for, related method of controlling a switch of, a power converter and a power converter employing the same. The controller is employable with a power converter including a switch of a power train configured to conduct for a duty cycle and provide a regulated output characteristic at an output thereof. In one embodiment, the controller includes a sparse analog-to-digital converter configured to determine a difference between the output characteristic and a desired characteristic and provide an error signal representing the difference in discrete steps. A magnitude of the discrete steps is small when the difference is small and the magnitude of the discrete steps is larger when the difference is larger. The controller also includes a duty cycle processor configured to provide a digital duty cycle signal to control the duty cycle of the switch as a function of the error signal.

Abstract: A controller for, related method of controlling a switch of, a power converter, and a power converter employing same. The controller is employable with a power train of a power converter including a switch configured to conduct for a duty cycle and provide a regulated output characteristic at an output thereof. In one embodiment, the controller includes an oscillator configured to provide a clock signal having multiple phases. The controller also includes a modulator configured to select a phase of the clock signal as a function of a portion of a digital duty cycle signal to refine a resolution of the duty cycle and provide a signal to control the duty cycle of the switch as a function of the digital duty cycle signal.

Abstract: A process and system for modeling, learning and synthesizing cursive handwriting in a user's personal handwriting style. The handwriting synthesis system and process described herein addresses the problem of learning the personal handwriting style of a user based on limited handwriting samples and producing novel scripts of the same style. The handwriting synthesis process includes segmenting handwriting samples into individual characters using a two-level writer-independent segmentation process, aligning samples of the same character into a common coordinate frame, and learning and modeling the individual character. Synthesis of handwriting is performed by generating individual letters from the models and concatenating the letters using a conditional sampling algorithm. The result is a smooth and fluid connection between letters that successfully mimics the personal handwriting style of a user.

Abstract: An organic light-emitting diode (OLED) comprises a transparent substrate, a first electrode, at least one organic functional layer, a second electrode, and a lid. The first electrode is disposed on the transparent substrate, the organic functional layer is disposed on the first electrode, the second electrode is disposed on the organic functional layer, and the lid is disposed above the second electrode. The lid has at least one heat-dissipating pin mounted on the lid. Furthermore, the lid is composed of a covering component and a heat-dissipating component. The covering component is disposed on or above the second electrode, and the heat-dissipating component is disposed on the covering component.

Abstract: The invention generally relates to a method for pulmonary delivery of therapeutic, prophylactic and diagnostic agents to a patient wherein the agent is released in a sustained fashion, and to particles suitable for use in the method. In particular, the invention relates to a method for the pulmonary delivery of a therapeutic, prophylactic or diagnostic agent comprising administering to the respiratory tract of a patient in need of treatment, prophylaxis or diagnosis an effective amount of particles comprising a therapeutic, prophylactic or diagnostic agent or any combination thereof in association with a charged lipid, wherein the charged lipid has an overall net charge which is opposite to that of the agent upon association with the agent. Release of the agent from the administered particles occurs in a sustained fashion.

Abstract: Particles incorporating a surfactant and/or a hydrophilic or hydrophobic complex of a positively or negatively charged therapeutic agent and a charged molecule of opposite charge for drug delivery to the pulmonary system, and methods for their synthesis and administration are provided. In a preferred embodiment, the particles are made of a biodegradable material and have a tap density less than 0.4 g/cm3 and a mass mean diameter between 5 &mgr;m and 30 &mgr;m, which together yield an aerodynamic diameter of the particles of between approximately one and three microns. The particles may be formed of biodegradable materials such as biodegradable polymers. For example, the particles may be formed of poly(lactic acid) or poly(glycolic acid) or copolymers thereof. Alternatively, the particles may be formed solely of a therapeutic or diagnostic agent and a surfactant.

Abstract: A flat color-shift medium which is positioned on a backlight of an organic light-emitting source. The flat color-shift medium is made of uniformly mixed fluorescent materials, each of which has a specific dose ratio. Due to the microcosmic light-color mixing effect of the fluorescent materials, the flat color-shift medium could shift an original spectrum of shorter wavelength into a desired spectrum of longer wavelength.

Abstract: The invention generally relates to a method for pulmonary delivery of therapeutic, prophylactic and diagnostic agents to a patient wherein the agent is released in a sustained fashion, and to particles suitable for use in the method. In particular, the invention relates to a method for the pulmonary delivery of a therapeutic, prophylactic or diagnostic agent comprising administering to the respiratory tract of a patient in need of treatment, prophylaxis or diagnosis an effective amount of particles comprising a polycationic complexing agent which is complexed with a therapeutic, prophylactic or diagnostic agent or any combination thereof having a charge capable of complexing with the polycationic complexing agent upon association with the bioactive agent. The particles can further comprise a pharmaceutically acceptable carrier. The amount of polycationic complexing agent present in the particles is an amount sufficient to sustain the release of diagnostic, therapeutic or prophylactic agent from the particles.

Abstract: A process for producing a self-aligned contact comprises the steps of forming leads on a substrate, forming an etching stop layer on the leads by depositing, then forming a sacrificed oxide layer; after the structure of the leads is defined, a spacer is formed on both sides of the structure; a sacrificed oxide layer is formed, allowing the spacer to protrude in the form of horn. Next, a dielectric layer having a flat upper surface is deposited on the substrate and the structure of leads, a contact hole being formed between the leads so as to connect the substrate, a conductive material being filled in the contact hole to form a plug.

Abstract: A method of manufacturing a double gate oxide layer. A substrate has trenches that divide the substrate into a memory circuit region and a logic circuit region. A dielectric layer is formed on the substrate to fill the trenches. The dielectric layer of the logic region is removed, thereby exposing the substrate. An ion implantation step is performed on the substrate of the logic circuit region using a reverse tone mask. A conformal barrier layer is formed over the substrate. A spin-on layer is formed over the barrier layer. A chemical mechanical polishing step is performed to remove the in-on layer, the barrier layer, and dielectric layer outside the trenches, thereby exposing the substrate. A thermal oxidation step is performed to form a double gate oxide layer that is thicker in the logic circuit region than it is in the memory circuit region.

Abstract: The invention generally relates to a method for pulmonary delivery of therapeutic, prophylactic and diagnostic agents to a patient wherein the agent is released in a sustained fashion, and to particles suitable for use in the method. In particular, the invention relates to a method for the pulmonary delivery of a therapeutic, prophylactic or diagnostic agent comprising administering to the respiratory tract of a patient in need of treatment, prophylaxis or diagnosis an effective amount of particles comprising a therapeutic, prophylactic or diagnostic agent or any combination thereof in association with a charged lipid, wherein the charged lipid has an overall net charge which is opposite to that of the agent upon association with the agent. Release of the agent from the administered particles occurs in a sustained fashion.

Abstract: Particles incorporating a surfactant and/or a hydrophilic or hydrophobic complex of a positively or negatively charged therapeutic agent and a charged molecule of opposite charge for drug delivery to the pulmonary system, and methods for their synthesis and administration are provided. In a preferred embodiment, the particles are made of a biodegradable material and have a tap density less than 0.4 g/cm.sup.3 and a mass mean diameter between 5 .mu.m and 30 .mu.m, which together yield an aerodynamic diameter of the particles of between approximately one and three microns. The particles may be formed of biodegradable materials such as biodegradable polymers. For example, the particles may be formed of poly(lactic acid) or poly(glycolic acid) or copolymers thereof. Alternatively, the particles may be formed solely of a therapeutic or diagnostic agent and a surfactant.

Abstract: Disclosed is a method of inhibiting a rejection response by a primate to a transplanted organ. One exposes the primate to a mutant diphtheria toxin linked to anti-CD3 antibody so as to largely eliminate the host's peripheral blood T cell lymphocyte population. At the same time as, or after, the exposure step one administers to the primate's thymus gland donor lymphocytes. Transplantation of the organ follows. The primate is tolerized to the transplanted organ.